Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
The Journal of Experimental Medicine
|
October 31, 2007
Ets-1 is a negative regulator of Th17 differentiation
Jacques Moisan, Roland Grenningloh, Estelle Bettelli, et al.
FEMS Immunology and Medical Microbiology
|
May 19, 2006
Role of SLC11A1 (formerly NRAMP1) in regulation of signal transduction induced by Toll-like receptor 7 ligands
Jacques Moisan, Thusanth Thuraisingam, Jill Henault, et al.
The Journal of Investigative Dermatology
|
February 14, 2006
Delayed cutaneous wound healing in mice lacking solute carrier 11a1 (formerly Nramp1): correlation with decreased expression of secretory leukocyte protease inhibitor
Thusanth Thuraisingam, Hakeem Sam, Jacques Moisan, et al.
Vaccine
|
January 28, 2003
Recombinant congenic strains of mice: a new tool for the genetic dissection of efficacy and toxicity of adjuvants
Sergio Di Marco, Jacques Moisan, Marie-Linda Boghdady, et al.
European Journal of Immunology
|
May 10, 2008
Role of Ets-1 phosphorylation in the effector function of Th cells
Roland Grenningloh, Shi-Chuen Miaw, Jacques Moisan, et al.
Molecular Immunology
|
May 9, 2007
Distinct role of MAPKAPK-2 in the regulation of TNF gene expression by Toll-like receptor 7 and 9 ligands
Thusanth Thuraisingam, Yong Zhong Xu, Jacques Moisan, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 3, 2007
Chronic asthma-induced airway remodeling is prevented by toll-like receptor-7/8 ligand S28463
Pierre Camateros, Meiyo Tamaoka, Muhannad Hassan, et al.
Cancer Research
|
May 18, 2018
<i>In Vitro</i> Priming of Adoptively Transferred T Cells with a RORγ Agonist Confers Durable Memory and Stemness <i>In Vivo</i>
Xiao Hu, Kinga Majchrzak, Xikui Liu, et al.
Journal for Immunotherapy of Cancer
|
August 27, 2020
Preclinical investigations and a first-in-human phase I trial of M4112, the first dual inhibitor of indoleamine 2,3-dioxygenase 1 and tryptophan 2,3-dioxygenase 2, in patients with advanced solid tumors
Aung Naing, Joseph P Eder, Sarina A Piha-Paul, et al.
Journal for Immunotherapy of Cancer
|
October 28, 2025
Combination of a novel TCR Vβ chain-directed selective T cell activator with standard of care therapy for head and neck cancer improves antitumor responses and promotes regression of checkpoint-refractory tumor models
Francesca Rosato, Ginette Santiago-Sanchez, Kellsye P Fabian, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
The Journal of Experimental Medicine
|
October 31, 2007
Ets-1 is a negative regulator of Th17 differentiation
Jacques Moisan, Roland Grenningloh, Estelle Bettelli, et al.
FEMS Immunology and Medical Microbiology
|
May 19, 2006
Role of SLC11A1 (formerly NRAMP1) in regulation of signal transduction induced by Toll-like receptor 7 ligands
Jacques Moisan, Thusanth Thuraisingam, Jill Henault, et al.
The Journal of Investigative Dermatology
|
February 14, 2006
Delayed cutaneous wound healing in mice lacking solute carrier 11a1 (formerly Nramp1): correlation with decreased expression of secretory leukocyte protease inhibitor
Thusanth Thuraisingam, Hakeem Sam, Jacques Moisan, et al.
Vaccine
|
January 28, 2003
Recombinant congenic strains of mice: a new tool for the genetic dissection of efficacy and toxicity of adjuvants
Sergio Di Marco, Jacques Moisan, Marie-Linda Boghdady, et al.
European Journal of Immunology
|
May 10, 2008
Role of Ets-1 phosphorylation in the effector function of Th cells
Roland Grenningloh, Shi-Chuen Miaw, Jacques Moisan, et al.
Molecular Immunology
|
May 9, 2007
Distinct role of MAPKAPK-2 in the regulation of TNF gene expression by Toll-like receptor 7 and 9 ligands
Thusanth Thuraisingam, Yong Zhong Xu, Jacques Moisan, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 3, 2007
Chronic asthma-induced airway remodeling is prevented by toll-like receptor-7/8 ligand S28463
Pierre Camateros, Meiyo Tamaoka, Muhannad Hassan, et al.
Cancer Research
|
May 18, 2018
<i>In Vitro</i> Priming of Adoptively Transferred T Cells with a RORγ Agonist Confers Durable Memory and Stemness <i>In Vivo</i>
Xiao Hu, Kinga Majchrzak, Xikui Liu, et al.
Journal for Immunotherapy of Cancer
|
August 27, 2020
Preclinical investigations and a first-in-human phase I trial of M4112, the first dual inhibitor of indoleamine 2,3-dioxygenase 1 and tryptophan 2,3-dioxygenase 2, in patients with advanced solid tumors
Aung Naing, Joseph P Eder, Sarina A Piha-Paul, et al.
Journal for Immunotherapy of Cancer
|
October 28, 2025
Combination of a novel TCR Vβ chain-directed selective T cell activator with standard of care therapy for head and neck cancer improves antitumor responses and promotes regression of checkpoint-refractory tumor models
Francesca Rosato, Ginette Santiago-Sanchez, Kellsye P Fabian, et al.
Page
of 2